Cost‑effectiveness analysis of hexaminolevulinate (Hexvix®) guided cystoscopy in Non‑Muscle Invasive Bladder Cancer patients (NMIBC) in Italy

Cost‑effectiveness analysis of hexaminolevulinate (Hexvix®) guided cystoscopy in Non‑Muscle Invasive Bladder Cancer patients (NMIBC) in Italy

OBJECTIVE: To estimate the incremental cost‑effectiveness of hexaminolevulinate (Hexvix®) + Blue Light (H+BL) cystoscopy (compared to white light cystoscopy only) when used at initial transurethral resection of the bladder tumour (TURBT) for patients diagnosed with non‑muscle invasive bladder cancer...

Full description

Bibliographic Details
Main Authors: Craig Bennison, Stephanie Stephens, Giario Natale Conti
Format: Article
Language:English
Published: SEEd Medical Publishers 2014-09-01
Series:Farmeconomia: Health Economics and Therapeutic Pathways
Subjects:
cost‑effectiveness
hexvix®
cystoscopy
nmibc
Online Access:https://journals.seedmedicalpublishers.com/index.php/FE/article/view/944

Internet

https://journals.seedmedicalpublishers.com/index.php/FE/article/view/944

Similar Items